Cochlear implants and aural rehabilitation

In short

A cochlear implant (CI) is a surgically placed neural prosthesis that bypasses damaged cochlear hair cells and stimulates surviving spiral ganglion cells directly with electrical pulses, giving useful hearing to people whose severe-to-profound sensorineural loss cannot be helped enough by hearing aids. The device alone does not create listening skill: structured aural rehabilitation — MAPping, auditory training, speech-language therapy and family counselling — converts electrical hearing into speech understanding. BASLP exams test candidacy, device parts, coding strategies, programming parameters, telemetry, outcome measures and the rehabilitation hierarchy. In India the knowledge is used daily in CI clinics of AIISH Mysuru, NISH Thiruvananthapuram, AYJNISHD Mumbai, medical college ENT departments and private CI programmes, and in government-funded surgeries under the ADIP cochlear implant component with RCI-registered audiologists doing the switch-on and habilitation.

Explained

What the device is and how it works

• Principle: sound is converted into a patterned electrical current delivered to tonotopically arranged intracochlear electrodes; the auditory nerve is stimulated, so the cochlea's transduction stage (hair cells) is replaced, not repaired.
• External parts: microphone(s) → speech processor (BTE or single-unit/off-the-ear) → transmitting coil held by a magnet; plus battery (rechargeable or zinc-air), and accessories such as telecoil, FM/Roger, Bluetooth streaming, waterproof covers.
• Internal parts: receiver-stimulator package with internal magnet, placed in a bony bed/periosteal pocket behind the mastoid, and the electrode array inserted into the scala tympani of the basal turn.
• Signal path: acoustic signal → pre-processing (gain control, noise reduction, directional mic) → filter bank splitting the spectrum into bands → envelope extraction per band → compression into the patient's electrical dynamic range → biphasic current pulses to the matching electrode.
• Transcutaneous link: radiofrequency inductive coupling carries both power and data across intact skin; there is no percutaneous plug in current devices.
• Stimulation mode: monopolar (intracochlear active electrode, extracochlear ground) is standard — lower current, broader spread; bipolar is more focal but needs more current.
• Biphasic pulses (equal charge in opposite phases) are used so net charge is zero and tissue/electrode damage is avoided.

Types, electrodes and coding strategies

• Array types: straight/lateral wall arrays (sit near the outer wall, atraumatic, suit ossified or malformed cochleae) and perimodiolar/pre-curved arrays (hug the modiolus, lower thresholds, higher insertion-trauma risk).
• Special arrays: short/hybrid electro-acoustic stimulation (EAS) arrays for good residual low-frequency hearing; compressed/split arrays for ossified cochleae after meningitis; double array for severe ossification.
• Channel counts differ by manufacturer (commonly 12-22 intracochlear contacts); "channels" (independent information bands) and "electrodes" (physical contacts) are not synonymous — current steering can create virtual channels between contacts.
• Coding strategies:
  • CIS (Continuous Interleaved Sampling): all channels stimulated sequentially at a high rate, non-simultaneously, to avoid channel interaction.
  • SPEAK / ACE (n-of-m): each cycle picks the n highest-amplitude bands out of m bands — ACE uses a higher rate; SPEAK a lower one.
  • Fine-structure/current-steering strategies (FSP/FS4, HiRes with Fidelity 120): add temporal fine-structure or current-steering cues in apical channels to improve pitch, music and tonal-language perception.
  • Older analogue strategies (CA, SAS) are historical; MPEAK/F0F1F2 are feature-extraction ancestors asked in theory papers.
• Related implantable devices (distinguish in vivas): auditory brainstem implant (ABI) on the cochlear nucleus when the cochlear nerve is absent (NF2, cochlear nerve aplasia); bone-conduction implants (BAHA/Bonebridge) for conductive/mixed loss or single-sided deafness; active middle-ear implants for mixed loss; bimodal fitting = CI in one ear with a hearing aid in the other.

Candidacy, work-up and surgery

• Audiological criteria (broad, programme-dependent): bilateral severe-to-profound sensorineural loss (pure-tone average typically ≥ 70-90 dB HL in children, ≥ 70 dB in adults), limited benefit from well-fitted hearing aids after a documented aided trial (commonly aided open-set sentence/word scores below about 50-60%), and aided thresholds not giving access to speech.
• Age: earliest possible implantation gives the best outcome; regulatory and programme minimums have moved down to around 9-12 months, and government funding in India has focused on young children (ADIP has used an upper age limit for children — check the current scheme circular, as the ceiling and age have been revised more than once).
• Pre-operative test battery: otoscopy and immittance; PTA with masking; ABR/ASSR and OAE for cross-check in infants; aided audiogram and age-appropriate speech perception; HRCT temporal bone (ossification, malformation, facial nerve course) and MRI (cochlear patency, nerve presence, brain); vestibular assessment in adults; speech-language and pre-verbal communication evaluation; cognitive/psychological screening; paediatric medical fitness and pneumococcal vaccination.
• Absolute contraindications: Michel aplasia (no cochlea), absent cochlear nerve (then consider ABI), active middle-ear or mastoid infection until treated, and medical unfitness for anaesthesia.
• Relative/caution: complete ossification, cochlear malformations (risk of gusher/CSF leak), chronic suppurative otitis media (staged surgery), unrealistic family expectations, no access to rehabilitation.
• Surgical steps (outline): post-auricular incision → cortical mastoidectomy → posterior tympanotomy through the facial recess (between the facial nerve and chorda tympani) → identify round window → round window insertion or cochleostomy → insert array, seal → seat receiver-stimulator → intra-operative impedance and ECAP telemetry plus X-ray/fluoroscopy to confirm placement.
• Complications: facial nerve injury, taste change, CSF leak/gusher, wound infection or flap breakdown, device migration or hard/soft failure, vertigo, tinnitus, meningitis (hence vaccination), and loss of residual hearing.
• Minimally traumatic ("soft") surgery — slow insertion, round window approach, steroid cover — is used to preserve residual hearing for EAS.

Programming: switch-on and MAPping

1. Switch-on is usually 2-4 weeks after surgery once the wound has healed.
2. Impedance telemetry first: checks each electrode for open circuit (very high impedance) or short circuit (very low); typical acceptable values lie in the low kilo-ohm range, and out-of-range electrodes are deactivated.
3. Set T (threshold) level — the softest current the patient reliably detects — and C/M (comfort/most comfortable) level — loud but comfortable, never uncomfortable; in infants these are estimated from behavioural observation, loudness scaling with toys/pictures, and objective measures.
4. Objective aids to MAPping: ECAP recordings (NRT/ART/NRI by manufacturer name), ESRT (electrically evoked stapedial reflex threshold, a good proxy for upper levels) and EABR; ECAP thresholds usually fall between T and C and are used to shape the profile, not to replace behavioural levels.
5. Loudness balancing across electrodes (sweep) and global loudness adjustment so the whole MAP sounds even and comfortable.
6. Other MAP parameters: stimulation rate per channel, pulse width, maps/programmes, frequency allocation table, IDR/input dynamic range (commonly around 40-80 dB in current processors), sensitivity, AGC/compression, maxima (for n-of-m), and pre-processing options (ADRO, ClearVoice, autosensitivity, wind/noise managers).
7. Follow-up schedule: frequent in the first 3 months, then tapering to 6-monthly/annual; each visit does telemetry, re-MAPping, aided free-field warble-tone thresholds (target roughly 20-30 dB HL across 250-4000 Hz), speech perception testing and datalogging review for actual hours of use and environments.
8. Troubleshooting: no sound (coil, cable, battery, magnet strength), intermittency, facial nerve stimulation (deactivate or reduce the offending electrode, widen pulse width), non-auditory sensation, sudden drop in performance (suspect device failure → integrity testing).

Aural rehabilitation

• Goal: develop auditory perception, spoken language, speech production and communication participation appropriate to the child's hearing age, or re-train an adult's degraded auditory speech code.
• Approaches: auditory-verbal therapy (AVT) — listening and spoken language with parent as primary agent, hearing technology worn all waking hours; auditory-oral; total communication; bilingual-bicultural. Choice is a family decision after informed counselling.
• Erber's hierarchy of auditory skills: detection → discrimination → identification → comprehension, each worked through closed set to open set, quiet to noise, and with increasing linguistic load.
• Core activities: Ling six-sound test (/m, u, a, i, ʃ, s/) daily to verify audibility across the spectrum; auditory feedback for speech; suprasegmental work (duration, intensity, pitch); phonological and vocabulary building; narrative and literacy; listening in noise and telephone training; music and environmental sound awareness.
• Adults and post-lingually deafened users: auditory training with analytic (phoneme/word) and synthetic (sentence/discourse) tasks, lip-reading as a support, communication-repair strategies, counselling for expectations, and vocational/tinnitus management.
• Family-centred practice: parent coaching, home programme, language-rich routines, school liaison, classroom acoustics and FM/remote microphone advice, teacher sensitisation.
• Outcome measures (know the scales): CAP (Categories of Auditory Performance, 0-7; CAP-II extends it to 0-9), SIR (Speech Intelligibility Rating, 1-5), IT-MAIS/MAIS, LittlEARS auditory questionnaire for infants, PEACH/TEACH, MUSS (meaningful use of speech), speech identification scores in the child's own language, and language measures; Indian-language word and sentence lists (Hindi, Kannada, Malayalam, Tamil, Telugu, Marathi, Bengali, among others) developed largely at AIISH/NISH are used instead of translating English tests.
• Prognostic factors: age at implantation, duration of deafness, pre-implant residual hearing and aided experience, aetiology and cochlear nerve status, cognitive and additional disabilities, consistent device use (datalogging), language of the home, and quality/quantity of rehabilitation.

Indian framework, schemes and professional practice

• Rehabilitation Council of India Act, 1992: audiologists and speech-language pathologists must hold RCI registration (CRR) to practise, and must earn continuing rehabilitation education (CRE) credits — practising or testing without registration is an offence under the Act.
• RPwD Act, 2016: recognises "deaf" and "hard of hearing" as specified disabilities; benchmark disability is 40% or more, certified on the prescribed hearing-disability guidelines; gives rights to reasonable accommodation, inclusive education, 4% reservation in government posts (for the specified group including hearing impairment) and free education up to 18 years in the relevant category.
• ADIP scheme (Department of Empowerment of Persons with Disabilities) funds cochlear implantation with a per-child ceiling (publicly reported at about ₹6 lakh for the device and surgery plus a separate allowance of roughly ₹50,000 for post-implant rehabilitation); ALIMCO is a main implementing agency and empanelled hospitals perform the surgery. Treat the amounts, the age ceiling and income limits as subject to revision — verify the current circular before counselling a family.
• NPPCD (National Programme for Prevention and Control of Deafness) covers screening, awareness and capacity building; RBSK screens children for hearing loss; state schemes (for example in Kerala, Tamil Nadu, Maharashtra, Delhi, Andhra Pradesh and Telangana) and PM-JAY/CGHS/ESIC/state insurance packages fund implants in varying measure.
• Cost reality for counselling: a commercial implant plus surgery typically runs into several lakh rupees, with lifelong recurring costs for batteries, coils, cables, processor upgrades and therapy visits — these must be disclosed before surgery.
• Ethics and consent: informed consent covering realistic outcomes, device failure and revision, the Deaf-community perspective on paediatric implantation, and the need for a committed rehabilitation plan before listing a child.

Key points

• Cochlear implant - prosthesis that electrically stimulates the auditory nerve, bypassing non-functioning hair cells.
• Internal/external split - receiver-stimulator plus electrode array inside; microphone, processor and coil outside, linked by RF induction.
• Scala tympani - the target space for the array; the basal turn codes high frequencies, the apex low (tonotopy).
• Monopolar biphasic stimulation - standard mode; charge-balanced pulses prevent tissue and electrode damage.
• T level - softest detectable current; C/M level - loud but comfortable upper limit; the gap between them is the electrical dynamic range.
• Electrical dynamic range is narrow (tens of current units), so a wide acoustic input range is compressed into it by the processor's IDR and compression.
• CIS - all channels, sequential, high rate; ACE/SPEAK - n-of-m peak picking; FSP/HiRes 120 - fine structure and current steering.
• Impedance telemetry detects open and short circuits; ECAP (NRT/ART/NRI) estimates stimulation levels objectively; ESRT approximates comfort level.
• Switch-on at about 2-4 weeks post-surgery, followed by intensive re-MAPping in the first three months.
• Aided target - free-field warble-tone thresholds around 20-30 dB HL from 250 to 4000 Hz after optimal MAPping.
• Erber's hierarchy - detection, discrimination, identification, comprehension; the backbone of auditory training.
• Ling six sounds - /m, u, a, i, ʃ, s/; a one-minute daily check of audibility across the speech spectrum.
• Hearing age - time since switch-on; expectations are set against hearing age, not chronological age.
• CAP (0-7) and SIR (1-5) - quick clinician-rated outcome scales; IT-MAIS, LittlEARS, PEACH are parent questionnaires.
• ABI is for absent cochlea/cochlear nerve; bone-conduction and middle-ear implants are for conductive and mixed loss, not for profound SNHL.
• Facial nerve stimulation - a programming complication (often with otosclerosis or cochlear otospongiosis); managed by deactivating electrodes, lowering levels or widening pulse width.
• Pneumococcal vaccination before implantation reduces meningitis risk.
• RCI registration is mandatory to practise; RPwD Act, 2016 sets the disability-certification and rights framework; ADIP is the main central funding route for paediatric implants.

Formulas and examples

Example 1 - dynamic range and MAP shape. On electrode 10, T = 102 CU and C = 182 CU; on electrode 20, T = 95 CU and C = 150 CU.

• DR(E10) = 182 − 102 = 80 CU; DR(E20) = 150 − 95 = 55 CU.
• The apical electrode has the narrower range, so the same acoustic increase produces a bigger loudness jump there — loudness balancing and per-channel gain are needed, not a single global setting.
• If the processor maps a 60 dB input dynamic range into DR(E20), each dB of input ≈ 55/60 ≈ 0.92 CU, i.e. less than one current step per decibel.

Example 2 - stimulation rate and whether it is achievable. A 12-channel MAP is set to 1,200 pps per channel with pulse width 25 µs and inter-phase gap 8 µs.

• R_total = 12 × 1,200 = 14,400 pps.
• Time available per cycle = 1/1,200 s = 833 µs.
• Time needed = 12 × (2 × 25 + 8) = 12 × 58 = 696 µs → 696 < 833, so the rate is achievable.
• If pulse width were raised to 40 µs: 12 × (80 + 8) = 1,056 µs > 833 µs → the software would have to reduce the rate or the maxima. This is why widening pulse width (to cut current) forces a rate trade-off.

Example 3 - charge per phase. Current 900 µA with a 25 µs pulse width.

• Q = 900 × 10⁻⁶ A × 25 × 10⁻⁶ s = 2.25 × 10⁻⁸ C = 22.5 nC per phase.
• To keep the same charge at 450 µA, PW must double to 50 µs (450 µA × 50 µs = 22.5 nC) — the clinical basis for trading current against pulse width when compliance limits or facial stimulation appear.

Example 4 - electrode integrity. Telemetry reports 1.4 V across an electrode carrying 200 µA.

• Z = 1.4 / (200 × 10⁻⁶) = 7,000 Ω = 7 kΩ — within the usual working band.
• A reading of 0.02 V at the same current gives Z = 100 Ω → short circuit; "out of compliance / no reading" suggests an open circuit. Both electrodes are deactivated and the MAP re-balanced.

Example 5 - outcome tracking in a child. Implanted at 2 years 2 months, switched on at 2 years 6 months, now 5 years 0 months. Kannada PB word identification (recorded, 65 dB SPL, quiet): 36 correct out of 50; in +5 dB SNR noise: 22/50.

• Hearing age = 5 y 0 m − 2 y 6 m = 2 years 6 months.
• Quiet score = (36/50) × 100 = 72%; noise score = (22/50) × 100 = 44%.
• Interpretation: language is judged against a 2.5-year hearing age, not a 5-year-old norm; the 28-point drop in noise justifies a remote microphone/FM system in class and noise-specific auditory training.

Where it is used

• Tertiary CI programmes: AIISH Mysuru, NISH Thiruvananthapuram, AYJNISHD Mumbai, AIIMS and other medical-college ENT departments, and large private hospital chains — audiologists do candidacy evaluation, intra-operative telemetry, switch-on, MAPping and long-term follow-up.
• Government schemes: ADIP cochlear implant work with ALIMCO and empanelled hospitals; NPPCD district-level screening and referral; RBSK school and infant screening feeding candidates into the pathway.
• Manufacturer and distributor roles in India: clinical application specialist, product trainer and technical support posts with cochlear implant companies and their Indian distributors — testing, MAPping support, troubleshooting, surgeon and audiologist training.
• Early intervention and schools: AVT therapists, special educators and early-intervention centres running parent-coaching programmes; resource rooms and inclusive schools managing FM systems and classroom acoustics.
• Private audiology and speech clinics: pre-implant aided trials, post-implant therapy, device accessory sales and service, insurance and ADIP documentation.
• Research and teaching: Indian-language speech perception test development, electrophysiology (ECAP, EABR, cortical responses), outcome studies on age at implantation, and BASLP/MASLP teaching and clinical supervision.

Interview questions

• Q: How does a cochlear implant differ in principle from a hearing aid? A: A hearing aid amplifies acoustic sound for surviving hair cells; an implant converts sound into electrical pulses that stimulate the auditory nerve directly, bypassing the hair cells altogether.
• Q: What are T and C levels, and why is the electrical dynamic range important? A: T is the softest detectable current and C the loudest comfortable one; the range between them is narrow, so the processor must compress a wide acoustic input range into it — an error in either level makes speech inaudible or uncomfortable.
• Q: Which objective measures help you MAP an infant who cannot give behavioural responses? A: Impedance telemetry for electrode integrity, ECAP (NRT/ART/NRI) to shape the level profile, and ESRT or EABR to estimate comfortable levels — always cross-checked with behavioural observation and aided thresholds as the child matures.
• Q: Why are biphasic pulses used? A: They deliver equal and opposite charge so net charge is zero, preventing electrochemical damage to the electrode and the surrounding tissue.
• Q: What is the difference between CIS and ACE? A: CIS stimulates every channel sequentially each cycle; ACE is an n-of-m strategy that selects only the highest-amplitude bands per cycle, allowing more channels to be scanned at a high rate.
• Q: A child's performance drops suddenly after six good months. How do you proceed? A: Check the external kit and coil first, review datalogging, then run impedance and ECAP telemetry and integrity testing; if the device is sound, look at middle-ear status, MAP drift and non-use before concluding device failure.
• Q: What causes facial nerve stimulation and how is it managed? A: Current spread to the facial nerve, more common in otosclerosis or cochlear otospongiosis; manage by lowering the level on or deactivating the offending electrode, widening pulse width to use less current, or changing stimulation mode.
• Q: Why is an adequate hearing-aid trial required before implantation? A: Candidacy depends on demonstrating limited benefit from optimally fitted amplification; without a verified trial you cannot prove the child or adult needs an implant, and funding bodies require that documentation.
• Q: What is hearing age and why does it matter in therapy? A: It is the time elapsed since switch-on; auditory and language goals must be set against hearing age rather than chronological age, otherwise expectations and test interpretation are both wrong.
• Q: Name the stages of Erber's auditory hierarchy with one task each. A: Detection (respond to the Ling /s/), discrimination (same/different for two words), identification (pick the named picture from a set) and comprehension (answer a question about a short story).
• Q: When would you recommend an auditory brainstem implant instead of a cochlear implant? A: When the cochlea is absent (Michel aplasia), the cochlear nerve is aplastic, or the nerve has been lost — typically in NF2 after vestibular schwannoma surgery.
• Q: What legal and funding framework governs paediatric implantation in India? A: Practice requires RCI registration under the RCI Act, 1992; rights and certification come under the RPwD Act, 2016; central funding is chiefly through the ADIP cochlear implant component with ALIMCO and empanelled hospitals, with state and insurance schemes alongside — the exact ceilings and age limits are revised periodically and must be checked.

Common mistakes

• Saying an implant "restores normal hearing" — it gives useful, degraded electrical hearing whose spectral resolution is far coarser than normal, and outcomes vary widely.
• Confusing electrodes with channels, or quoting a channel count as if it were a measure of quality.
• Setting C levels from ECAP thresholds alone without behavioural loudness judgements and loudness balancing.
• Omitting impedance telemetry at the start of a session and then chasing a "programming problem" that is an open or short circuit.
• Forgetting that widening pulse width to reduce current limits the maximum achievable stimulation rate.
• Testing a child with English word lists or norms when validated lists in the child's own language exist, and interpreting scores against chronological rather than hearing age.
• Treating the implant as the endpoint — skipping family counselling, consistent full-time use, datalogging review and structured auditory-verbal work, which are what actually produce speech and language.

Related topics

Diagnostic audiology: audiometry, immittance, OAE and ABR · Paediatric audiology and newborn hearing screening · Hearing aids: selection and fitting · Auditory electrophysiology and neural response telemetry · Speech and language development in hearing loss · Disability legislation and rehabilitation schemes in India.